NXL-002

N/A

Report date: 2024/11/08 10:19:01

Base Information

Drug NameNXL-002
Drug Alias NameNXL-002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNeurogenic differentiation factor 1 stimulantsHomeobox protein DLX-2 stimulants
TargetsNeurogenic differentiation factor 1Homeobox protein DLX-2
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuExcell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuExcell Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A